Executive Director, Field Operations Strategy & Excellence at Travere Therapeutics in San Diego, CA

Job description

Department: 104400 Commercial Insights & Operations Location: San Diego, USA- Remote Be a part of a global team that is inspired to make a difference in the lives of people living with rare disease. At Travere Therapeutics, we recognize that our exceptional employees are vital to our success. We are a dedicated team focused on meeting the unique needs of rare patients. Our work is rewarding – both professionally and personally – because we are making a difference. We are passionate about what we do. We are seeking talented individuals who will thrive in our collaborative, diverse, fast-paced environment and share in our mission – to identify, develop and deliver life-changing therapies to people living with rare disease. We stick by our values centered on patients, courage, community, and collaboration to pursue our vision of becoming a leading biopharmaceutical company dedicated to the delivery of innovation and hope to patients in the global rare disease community. At Travere Therapeutics, we are in rare for life. We continue to courageously forge new paths as we move toward a common goal of elevating science and service for rare patients . Position Summary The Executive Director, Field Operations Strategy & Excellence provides enterprise leadership for the design, deployment, and performance of Travere’s customer-facing commercial field organization. The role establishes the field model needed to support FILSPARI, pegtibatinase planning, and future portfolio growth while ensuring that field investments translate into measurable business and patient impact. This leader owns field force strategy, structure and sizing, targeting, territory design, field performance analytics and reporting, incentive compensation strategy, sales force effectiveness initiatives, and launch deployment planning. The Executive Director partners closely with Sales, Marketing, Omnichannel, Market Access, Patient Services, Forecasting, Commercial Analytics, Commercial Systems, Finance, Human Resources, Legal, and Compliance. Responsibilities: Enterprise field strategy and deployment Develop and maintain a multi-year field strategy aligned to the commercial portfolio, brand priorities, customer needs, and expected launch sequence. Oversee field force sizing, role design, structure, coverage, territory alignment, and targeting across Sales, Access and Reimbursement Managers, Strategic Account Managers, Rare Kidney Disease Educators, Thought Leader Liaisons, and other customer-facing teams. Build deployment scenarios for pegtibatinase and future assets, including capability requirements, timing, resource implications, and organizational tradeoffs. Evaluate field investments and recommend changes to capacity, roles, territories, and customer coverage as business conditions evolve. Field performance and analytics Set the field performance measurement framework, including leading indicators, outcome measures, management reports, and executive-level performance reviews. Lead the integration of field analytics, patient and access analytics, and business context so that insights identify specific actions, owners, and expected outcomes. Partner with Commercial Analytics to align analytical methods, common definitions, measurement standards, and advanced analytics use cases. Ensure field dashboards and recurring reports answer priority business questions and reduce low-value reporting activity. Incentive compensation strategy and governance Establish incentive compensation principles and provide strategic direction for plan design, goal setting, measurement, contests, awards, and plan evaluation. Provide senior oversight of the annual incentive compensation process Chair or support incentive compensation governance and ensure plans align with business strategy, financial objectives, employee motivation, data quality, and applicable policies. Partner with Sales leadership, Finance, Human Resources, Legal, and Compliance on plan recommendations and material change